| S |
|
SAFE AND LONG-TERM EXPRESSION OF FVIII FOLLOWING SUBCUTANEOUS IMPLANTATION OF GENETICALLY-MODIFIED ENDOTHELIAL PROGENITORS IN HEMOPHILIA A MICE
|
| Matsui H., Shibata M., Ozelo M., Labelle A., Hegadorn C., Thompson P., Galipeau J., Hough C., Lillicrap D. |
| |
|
SAFETY AND EFFICACY OF NADROPARIN FOR THE MANAGEMENT OF VENOUS THROMBOEMBOLISM OR THROMBOPHILIA IN PREGNANCY
|
| Barillari G., Springolo F., Daminato R., Driul L., Turello M., Marchesoni D. |
| |
|
SAFETY AND EFFICACY OF TINZAPARIN ADMINISTRATION DURING PREGNANCY
|
| Kotsi P., Tsoucala C., Anastasopoulou I., Sarantopoulos A., Kanellopoulou G., Adraktas T., Karafoulidou A. |
| |
|
SAFETY AND EFFICACY OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE FOR PROPHYLAXIS DURING ELECTIVE SURGERY IN SUBJECTS WITH VON WILLEBRAND DISEASE
|
| Bernstein J., Gill J.C., Leissinger C.A., DiPAOLA J., Ragni M.V., Shopnick R., Valentino L.A., Friedman C., Knaub S. |
| |
|
SAFETY AND TOLERABILITY OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 IN PREVENTION OF STROKE AND OTHER THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH ATRIAL FIBRILLATION (AF)
|
| Olsson B., Rasmussen L.H., Tveit A., Jensen E., Wessman P., Panfilov S., Ekdal H.D., Wåhlander K. |
| |
|
SCREENING FOR OCCULT MALIGNANCY IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOEMBOLISM (VTE) EVALUATION (SOME TRIAL): A PROSPECTIVE PILOT COHORT STUDY USING COMPREHENSIVE ABDOMEN/PELVIS COMPUTED TOMOGRAPHY (CCT)
|
| Carrier M., Wells P.S., Tao H., Rodger M.A. |
| |
|
SCREENING FOR OCCULT MALIGNANCY IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOEMBOLISM. THE TROUSSEAU INVESTIGATORS
|
| van Doormaal F.F., Otten H., Buller H.R. |
| |
|
SCREENING FOR THROMBOPHILIA IN A RETROSPECTIVE STUDY OF 320 WOMEN WITH PREGNANCY COMPLICATIONS
|
| Slaoui M., Ajzenberg N., Dauge M., Scarabin C., Guillin M., Mahieu-Caputo D. |
| |
|
SCREENING FOR THROMBOPHILIA: RETROSPECTIVE STUDY IN WOMEN WITH GESTACIONAL VASCULAR COMPLICATIONS
|
| Mariz M., Corbillón L., Abreu Lima J., Pereira M., Matos R., Braga J., Morais S., Campos M. |
| |
|
SCUPA OR FXII STIMULATE ERK1/2 OR AKT THROUGH UPAR AND BETA 1 INTEGRINS
|
| Schmaier A.H., Mahdi F., Shariat-Madar Z., Sitrin R.G. |
| |
|
SECOND INTERIM ANALYSIS OF A LONG-TERM PHARMACOVIGILANCE PROJECT WITH A PLASMA DERIVED FVIII CONCENTRATE
|
| Klamroth R., Zimmermann R., Zacharias C., Knaub S., Kurnik K. |
| |
|
SECONDARY PROPHYLAXIS WITH RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN A SEVERE HAEMOPHILIA A PATIENT WITH ANTI-FACTOR VIII INHIBITORS
|
| Marquès-Verdier A., Chaleteix C., Soulié B., Bay J.O. |
| |
|
SECONDARY THROMBOPHYLAXIS USING ANTIPLATELET AGENTS AND LONG TERM MONITORING AFTER 1ST UNPROVOKED EPISODE OF VENOUS THROMBOEMBOLISM
|
| Papaioannou G., Papadakis E.S., Topalidou M., Braimi M., Korantzis I. |
| |
|
SECRETION OF COAGULATION FACTOR XIIIA FROM HAEMATOPOIETIC CELLS
|
| Cordell P.A., Grant P.J., Pease R.J. |
| |
|
SECRETORY PHOSPHOLIPASE A2 AND HIGH-SENSITIVITY C-REACTIVE PROTEIN IN CORONARY ARTERY DISEASE
|
| Lima L.M., Carvalho M.G., Neto C.P.F., Garcia J.C.F., Sousa M.O. |
| |
|
SECULAR TRENDS IN STUDIES EVALUATING VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS AFTER ORTHOPEDIC SURGERY (OS)
|
| Lazo-Langner A., Coyle D.A., Wells P.S., Scarvelis D., Forgie M.A., Rodger M.A. |
| |
|
SELECTIN HAPLOTYPES AND THE RISK OF VENOUS THROMBOSIS; INFLUENCE OF LINKAGE DISEQUILIBRIUM WITH THE FACTOR V LEIDEN MUTATION
|
| Uitte de Willige S., de Visser M.C.H., Vos H.L., Houwing-Duistermaat J.J., Rosendaal F.R., Bertina R.M. |
| |
|
SELECTIVE BINDING TO INTEGRIN ALPHA-9-INTEGRIN EXPRESSING CELLS OF MUTANTS OF DISINTEGRIN-LIKE DOMAIN OF ADAM-15 CONTAINING THE PUTATIVE INTEGRIN BINDING MOTIF OF ADAM-2, -12 AND -19, RESPECTIVELY
|
| Lu D., Xia M., Scully M., Lu X., Kakkar V. |
| |
|
SELECTIVE ENHANCEMENT OF PROTEIN S REAGENT SENSITIVITY BY BOVINE GAMMA GLOBULIN
|
| Cao Z., Bottenus R., Safa O., Vasquez J., Triscott M. |
| |
|
SELECTIVE SIGNALLING ROLE FOR PI 3-KINASE P110BETA IN THROMBIN-INDUCED CLOT RETRACTION
|
| Ono A., Lim J., Hamilton J.R., Jackson S.P., Schoenwaelder S.M. |
| |
|
SELF-CONTROL OF ORAL ANTICOAGULATION USING A PORTABLE PROTHROMBIN TIME MONITOR IN PAEDIATRIC CARDIAC PATIENTS
|
| Albisetti M., Schmugge M., Kaegi E., Bauersfeld U., Fasnacht M. |
| |
|
SELF-RATED HEALTH PREDICTS MORTALITY IN PATIENTS WITH HEMOPHILIA
|
| Plug I., Rosendaal F.R., van der Bom J.G. |
| |
|
SEMAPHORIN 3A ANTAGONIZES AGONIST-INDUCED PI3 KINASE PATHWAY IN PLATELETS
|
| Akiyama M., Kashiwagi H., Kamae T., Shiraga M., Tadokoro S., Honda S., Tomiyama Y., Kanakura Y. |
| |
|
SENSITIVITY AND SAFETY OF PULMONARY EMBOLI IMAGING WITH RADIOLABELED ANTI-D-DIMER MONOCLONAL ANTIBODY FRAGMENTS
|
| Morris T.A., Macfarlane D.J., Eisenberg P.R., Smart R.C., Gerometta M. |
| |
|
SENSITIVITY OF THE HEMOSIL THROMBOPATH ASSAY TO DEFECTS IN THE PROTEIN C ANTICOAGULANT PATHWAY
|
| Hickey K.P., Cooper P.C., Kitchen S. |
| |
|
SENSITIVITY OF THE PLATELET FUNCTION ANALYZER (PFA-100) AS A SCREENING TEST FOR LABORATORY DIAGNOSIS OF VON WILLEBRAND DISEASE
|
| Coen Herak D., Milos M., Zadro R. |
| |
|
SENSITIVITY TO ACTIVATED PROTEIN C (APC) IS INCREASED DURING THE SECRETORY PHASE OF THE MENSTRUAL CYCLE
|
| Brown D.L., Donnachie E., Escobar M., Rosas P., Griffin J., Hoots W. |
| |
|
SERIAL MONITORING OF ADAMTS13- AND VWF-RELATED PARAMETERS IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA: PREDICTION OF RESPONSE TO THERAPY, RISK OF RELAPSE, AND LONG-TERM COURSE
|
| Knoebl P.N., Koder S., Varadi K., Turecek P.L., Vetr H., Quehenberger P., Müllner C., Kolovratova V., Pabinger I. |
| |
|
SERIOUS BLEEDS IN HAEMOPHILIAC A CHILDREN AND CONTINUOUS INFUSION (CI)
|
| Pautard B., Tinot T., Li Thiao Te V., Horlé B., Vinciguerra C., Roussel B. |
| |
|
SEROTONERGIC MECHANISMS IN HAEMOSTASIS: A CONNECTION BETWEEN MAJOR DEPRESSION AND THROMBOTIC RISK
|
| Lopez-Vilchez I., Serra M., Alonso A., Navalon F., Hernandez R., Gomez E., Gasto C., Escolar G., Galan A.M. |
| |
|
SEROTONIN ENHANCES THE PROCOAGULANT PROPERTIES AND PLATELET ACTIVATION INDUCED DURING PLATELET UP TAKE OF TISSUE FACTOR
|
| Lopez-Vilchez I., Galan A.M., Diaz-Ricart M., Navalon F., White J.G., Escolar G. |
| |
|
SERPINS IN THROMBOSIS, HEMOSTASIS AND FIBRINOLYSIS
|
| Rau J.C., Beaulieu L.M., Huntington J.A., Church F.C. |
| |
|
SERUM ADIPONECTIN LEVELS & ITS CORRELATION WITH LIPIDS AND PROINFLAMMATORY MARKERS IN ASIAN INDIAN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE
|
| Rao V.S., Natesha B.K., Kanjilal S., Mukherjee M., Kakkar V.V. |
| |
|
SERUM BAFF LEVELS IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
|
| Zhou Z., Chen Z., Chen X., Zheng C., Xu J., Gu D., Du W., Huang Y., Yang R. |
| |
|
SERUM C-REACTIVE PROTEIN PLASMA LEVELS IN PATIENTS WITH ARTERIAL THROMBOSIS
|
| Sabino A.P., Carvalho M.G., Ribeiro D.D., Lima L.M., Sousa M.O., Dominheti C.P., Dusse L.M.S., Fernandes A.P.S.M. |
| |
|
SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
|
| Geisen C., Sittinger K., Spohn G., Dimichele D.M., Haubelt H., Heistinger M., Kadar J.G., Kemkes-Matthes B., Klamroth R., Lages P., Lindhoff-Last E., Luxembourg B., Mansouri Taleghani B., Pollmann H., Spannagl M., Zimmermann R., Seifried E., Oldenburg J. |
| |
|
SEVEN YEARS PHARMACOVIGILANCE EVALUATION WITH REFACTO: INHIBITOR DEVELOPMENT IN PREVIOUSLY TREATED AND UNTREATED HEMOPHILIA A PATIENTS
|
| Pollmann H. |
| |
|
SEVERE FACTOR VII DEFICIENCY DUE TO MUTATIONS IN THE FACTOR VII GENE PROMOTER
|
| Chafa O., Kastally R., Aubry M.L., Reghis A., Fischer A.M., Tapon-Bretaudière J. |
| |
|
SEVERE FACTOR XI DEFICIENCY IN A JEWISH CHILD CAUSED BY COMPOUND HETEROZYGOTY FOR A NOVEL NONSENSE MUTATION (TYR-14X, EXON 2) AND THE COMMON TYPE II MUTATION (GLU1 17X, EXON 5).L
|
| Neerman-Arbez M., De Moerloose P., Vieux L., Favier M., Favier R. |
| |
|
SEVERE FACTOR XI DEFICIENCY IN PREGNANT WOMEN: A PROTOCOL FOR LABOUR MANAGEMENT WITH FACTOR XI CONCENTRATE
|
| Salces M.M., Yuste V.J., Román M.A., Bello I.F., Garrido J.R., Molina M.Q., Navarro F.H. |
| |
|
SEVERE GASTRO-INTESTINAL BLEEDING AND THROMBOCYTOPENIA DUE TO AN ANTI-GATA AUTOANTIBODY
|
| Freson K., Thys C., Wittevrongel C., Van Geet C. |
| |
|
SEVERE GASTROINTESTINAL BLEEDING CAUSED BY ANGIODYSPLASIA IN A PATIENT WITH GLANZMANN THROMBASTHENIA
|
| Morais S., Corbillón L., Miranda M., Pinho N., Mariz M., Cleto E., Medina M., Campos M. |
| |
|
SEVERE HEMOPHILIA A AND FACTOR VIII INHIBITOR OCCURS IN A YOUNG GIRL WHO HAS A CARRIER MOTHER, TURNER SYNDROME AND CHROMOSOMAL STRUCTURAL ABNORMALITIES WITH 45,X(22)/46,X,IDIC(X)(Q21)(8)
|
| Lin H.Y., Chen M., Chang H.H., Yang Y.L., Chung C.Y., Chang C.S., Shen M.C. |
| |
|
SEVERE HYPOFIBRINOGENEMIA ASSOCIATED WITH MIDDLE CEREBRAL ARTERIAL THROMBOSIS
|
| Taouli K.K.T., Dali D.A., Benabadji C.S., Chafa C.O., Reghis R.A., Mesli M.N. |
| |
|
SEVERE NEONATAL ALLOIMMUNE THROMBOCYTOPENIA CAUSED BY LOW-AVIDITY ANTI-HPA-1A ALLOANTIBODIES
|
| Socher I., Andrei-Selmer C., Bein G., Kroll H., Santoso S. |
| |
|
SEVERE SPONTANEOUS ARTERIAL THROMBOTIC MANIFESTATIONS IN PATIENTS WITH INHERITED HYPO- AND AFIBRINOGENEMIA
|
| Castaman G., Lunardi M., Rigo L., Rodeghiero F. |
| |
|
SEX DIFFERENCE IN PLASMA SENSITIVITY TO TISSUE FACTOR RELATES TO THE LEVELS OF CIRCULATING PLATELET-DERIVED MICROPARTICLES
|
| Dotsenko O., Scully M.F., Kakkar A.K., Kakkar V.V. |
| |
|
SEX STEROIDS USED IN HORMONE TREATMENT ALTER COAGULATION GENE EXPRESSION IN CULTURED HUVEC
|
| Brosnan J.F., Sheppard B.L., Norris L.A. |
| |
|
SF-12 PHYSICAL COMPONENT SCORE IS AN INDEPENDENT PREDICTOR OF MAJOR HEMORRHAGE IN A COHORT OF ELDERLY PATIENTS ANTICOAGULATED FOR ATRIAL FIBRILLATION
|
| Brophy M.T., Young M., Gagnon D., Lawler E., Cantillon C., Fiore L.D. |
| |
|
SHEAR-INDUCED DISULFIDE BOND FORMATION REGULATES ADHESION ACTIVITY OF VON WILLEBRAND FACTOR
|
| Dong J., Choi H., Tao Z., Ball C., Nolasco L., Pownall H., Moake J. |
| |
|
SHORT TERM BETAINE ADMINISTRATION IN PATIENTS WITH COLLAGEN VASCULAR DISEASE-MEDIATED SEVERE PULMONARY ARTERIAL HYPERTENSION
|
| Iqbal O.M., Tona F., Fareed J., Cella G., Cunnanan J., Ennamany R., Messadek J. |
| |
|
SHORT-TERM OPTIMIZATION OF GLYCEMIC CONTROL WITH INTENSIVE INSULIN THERAPY DECREASE CIRCULATING PLATELET AND ENDOTHELIAL MICROPARTICLES LEVELS IN TYPE 2 DIABETIC PATIENTS
|
| Camoin-Jau L., Darmon P., Berda-Haddad Y., Sabatier F., Freyssinet J., Dutour A., Dignat-George F. |
| |
|
SHOULD COMMON INERITED THROMBOPHILIC ABNORMALITIES BE TESTED IN CANCER PATIENT WITH CENTRAL VENOUS CATHETER?
|
| Dentali F., Gianni M., Ageno W. |
| |
|
SIGNAL TRANSDUCTION PATHWAYS OF INTERLEUKIN-6 INDUCING TISSUE FACTOR EXPRESSION IN VASCULAR ENDOTHELIAL CELLS
|
| Wen Z., Li B., He X., Sun Y., Zhang H., Tang X., Hu J., Wang H., He S. |
| |
|
SIGNIFICANCE OF LOW-GRADE INFLAMMATION MARKERS AND SOLUBLE CELL ADHESION MOLECULES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
| Korzh I. |
| |
|
SIGNIFICANCE OF PLASMA SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR AND TISSUE FACTOR PATHWAY INHIBITOR IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
|
| Wahl D.G., Perret-Guillaume C., Kaminsky P., Lacolley P., Regnault V., Lecompte T. |
| |
|
SIGNIFICANCE OF PLASMA THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR LEVELS IN PATIENTS WITH ESSENTIAL HYPERTENSION
|
| Korzh I., Fedotova I. |
| |
|
SIGNIFICANT DISTINCTION BETWEEN PLASMA- AND PLATELET-DEPENDENT COAGULATION ACTIVITY IN HEMOPHILIA A PATIENTS
|
| Wartiovaara-Kautto U.M.K., Ilveskero S., Joutsi-Korhonen L., Lemponen M., Kuukka K., Armstrong E., Lassila R. |
| |
|
SIGNIFICANT REDUCTION OF VASCULAR GRAFT OCCLUSIONS IN CHRONIC HEMODIALYSIS PATIENTS WITH PEG-HIRUDIN (SPP200)
|
| Mann J., Kuranoff S.J., Navarro I., Russo J. |
| |
|
SIGNIFICANT VARIATION IN THROMBIN GENERATION POTENTIAL IN "ADEQUATELY" ANTICOAGULATED PATIENTS
|
| Gatt A., van Veen J.J., Bowyer A., Cooper P.C., Kitchen S., Makris M. |
| |
|
SILENCING OF A TARGETED PROTEIN IN IN VIVO PLATELETS USING A LENTIVIRAL VECTOR DELIVERING SHORT HAIRPIN RNA SEQUENCE
|
| Ohmori T., Kashiwakura Y., Ishiwata A., Madoiwa S., Mimuro J., Sakata Y. |
| |
|
SIMPLE COAGULATION TESTS IMPROVE EARLY MORTALITY PREDICTION IN ICU PATIENTS WITH SEPTIC SHOCK
|
| Lissalde-Lavigne G., Combescures C., Dorangeon E., Muller L., Bengler C., Lefrant J.Y., Gris J.C. |
| |
|
SIMULTANEOUS BLEEDING AND THROMBOSIS AS THE INITIAL PRESENTATION OF SUPERWARFARIN POISONING
|
| De Paula E.V., Annichino-Bizzacchi J.M., Montalvao S.L., Madureira P.R., Pinto R.V., Ozelo M.C. |
| |
|
SIMULTANEOUS GENOTYPING OF FXI TYPE II AND TYPE III MUTATIONS BY MULTIPLEX REAL-TIME PCR IN HEALTHY ITALIANS AND IN FXI-DEFICIENT PATIENTS
|
| Zadra G., Asselta R., Tenchini M.L., Seligsohn U., Castaman G., Duga S. |
| |
|
SIMULTANEOUS INHIBITION OF TAFI AND PAI-1 BY A HETERODIMER DIABODY
|
| Develter J., Dewilde M., Verbeke K., Declerck P.J., Gils A. |
| |
|
SIMVASTATIN-INDUCED ENDOTHELIAL CELL DETACHMENT AND MICROPARTICLE RELEASE ARE PRENYLATION DEPENDENT
|
| Diamant M., Tushuizen M.E., Abid-Hussein M.N., Hau C.M., Böing A.N., Sturk A., Nieuwland R. |
| |
|
SINGLE AND COMBINED EFFECTS OF GENE VARIANTS ON PLASMA TOTAL HOMOCYSTEINE LEVELS: RESULTS OF A CANDIDATE GENE APPROACH IN A POPULATION SAMPLE
|
| Vermeulen S.H.H.M., Heil S.G., Gellekink H., Kluijtmans L.A.J., Blom H.J., den Heijer M. |
| |
|
SINGLE MOLECULE FORCE SPECTROSCOPY OF FIBRINOGEN
|
| Lim B.B., Jahangir A. |
| |
|
SIRTINOL INHIBITS HUMAN PLATELETS AGGREGATION AND Ca2+ RELEASE
|
| Liu F.C., Liao C.H., Chang Y.W., Liou J.T., Day Y.J. |
| |
|
SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
|
| Murphy J.E., Pan C., Barnett T., Mei B., Strauss J., Tjandra H., Tang L., Esmon P., Newgren J., Landskroner K., Parmathi M., Severs J., Teare J., Jiang H., Devens B., Pierce G., Konstantinov K., Fournel M. |
| |
|
SIX ADULT ONSET TTP PATIENTS WITH SEVERAL ADAMTS13 POLYMORPHISMS AND A MISSENSE MUTATION (R1060W) THAT EXHIBITS DEFECTIVE SECRETION IN VITRO
|
| Camilleri R.S., Cohen H., Mackie I.J., Scully M., Starke R.D., Crawley J.T.B., Lane D.A., Machin S.J. |
| |
|
SKIZZLE, A NOVEL PLASMIN(OGEN) BINDING PROTEIN AND PLASMINOGEN ACTIVATOR FROM STREPTOCOCCUS AGALACTIAE
|
| Wiles K.G., Panizzi P., Bock P.E. |
| |
|
SMOKING INCREASES THE RISK OF VENOUS THROMBOSIS
|
| Pomp E.R., Rosendaal F.R., Doggen C.J.M. |
| |
|
SMOOTH MUSCLE-DERIVED TISSUE FACTOR IS CRITICAL FOR ARTERIAL THROMBOSIS AFTER FECL3 INJURY
|
| Wang L., Miller C.M., Rao M., Mackman N., Taubman M.B. |
| |
|
SNAPSHOT OF WARFARIN TREATMENT IN DIFFERENT SETTINGS: A CROSS SECTION STUDY IN SWEDISH PRIMARY HEALTH CARE CENTERS VS ANTICOAGULATION CLINICS
|
| Arbring K., Lindahl T.L. |
| |
|
S-NITROSYLATION OF THE PLATELET INTEGRIN ALPHA IIB BETA 3
|
| O'Neill S., Corrigan N., Walsh G.M., Leane D., Moran N., Keyes T.E., Forster R.J., Kenny D. |
| |
|
SNPS NEAR THE ESTROGEN SULFOTRANSFERASE GENE SULT1E1 AND THE RISK OF VENOUS THROMBOSIS IN RELATION TO ORAL CONTRACEPTIVE USE
|
| Vos H.L., van Hylckama Vlieg A., Rosendaal F.R. |
| |
|
SOCIAL COSTS OF ANTICOAGULANT TREATMENT FOR ATRIAL FIBRILLATION
|
| Filippucci E., Blass A., Parise P., Grasselli S., Ascani A., Brunetti F., Verducci M., Fattore G., Aguzzi G., Colangelo I., Agnelli G. |
| |
|
SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR AND CYTOKINE LEVELS IN TURKISH PEDIATRIC STROKE PATIENTS
|
| Yürürer D., Deda G., Egin Y., Akar N. |
| |
|
SOLUBLE P-SELECTIN AND THE RISK OF THROMBOTIC EVENTS IN PATIENTS WITH A LUPUS ANTICOAGULANT IN A PROSPECTIVE COHORT STUDY
|
| Vormittag R., Panzer S., Ay C., Quehenberger P., Koder S., Pabinger I. |
| |
|
SOLUBLE P-SELECTIN RESPONSE IN PRE AND FULL-TERM NEWBORNS WITH SEPSIS
|
| Morcos H.H., Iskander I.F., Goubran H.A. |
| |
|
SOURCE AND USE OF REFERENCE RANGES IN HAEMOSTASIS: PRACTICE AMONGST UK NEQAS FOR BLOOD COAGULATION PARTICIPANTS 2005-6
|
| Jennings I., Kitchen D.P., Kitchen S., Woods T.A.L., Walker I.D. |
| |
|
SOURCE OF TISSUE FACTOR LEADING TO DISCREPANT PLASMA FVII LEVELS IN EIGHT FVII-DEFICIENT PATIENTS OF AFRICAN ORIGIN
|
| Horellou M.H., Chalendard J., Juin F., Conard J., Gouault-Heilmann M., Tapon-Bretaudière J. |
| |
|
SOUTH EAST ENGLAND THROMBOTIC THROMBOCYTOPENIC PURPURA REGISTRY
|
| Scully M., Yarranton H., Liesner R., Cavenagh J., Hunt B., Benjamin S., Machin S. |
| |
|
SPANISH CONSENSUS STATEMENT ON PHARMACOLOGIC ALTERNATIVES TO ALLOGENEIC BLOOD TRANSFUSIONS: THE SEVILLE'S DOCUMENT*
|
| Páramo J.A., Leal S., Munoz M., Garcia-Erce J. |
| |
|
SPANISH REGISTRY OF HEPARIN-INDUCED THROMBOCYTOPENIA (RETIH). PRELIMINARY DATA
|
| Lopez Fernandez M., Andon Saavedra C., RETIH Group |
| |
|
SPATIO-TEMPORAL CALCIUM SIGNALING ELICITED BY INTEGRIN ALPHA2-BETA1 AND GLICOPROTEIN VI UNDER FLOW
|
| Mazzucato M., Cozzi M.R., Battiston M., Jandrot-Perrus M., Ruggeri Z.M., De Marco L. |
| |
|
SPECIFIC AND SENSITIVE DETECTION OF THE INHIBITION OF THE PLATELET P2Y12-RECEPTOR WITH THE PFA-100 SYSTEM USING A NEW CARTRIDGE DESIGN
|
| Rechner A.R., Schwarz M., Oehler C., Zander N. |
| |
|
SPECIFIC CYSTEINE RESIDUES IN BETA3 ARE ESSENTIAL FOR DISULFIDE BOND EXCHANGE- DEPENDENT OR -INDEPENDENT PATHWAYS OF ALPHAIIBBETA3 ACTIVATION
|
| Mor-Cohen R., Rosenberg N., Landau M., Lahav J., Seligsohn U. |
| |
|
SPECIFIC MULTI-RULE EXPERT SYSTEM FOR ELDERLY INPATIENT ANTICOAGULANT CONTROL
|
| Siguret V., Vieillefond V., Visseaux C., Levy C., Boccara C., Bal dit Sollier C., Cambus J., Drouet L., Mahé I., Horellou M., Pautas E., Gouin-Thibault I. |
| |
|
SPECIFIC PHENOTYPE OF PLATELETS GPIB, GPIIB, GPIIIA AND GMP-140 IN PATIENTS WITH LOW LIMB VARICOSE VEIN DISEASE
|
| Sivachenko Y.B., Kurtova A.V., Ryzhak A.P., Zueva Y.E., Kadinskaya M.I., h. Vahitov M.S. |
| |
|
SPECIFIC ROLES OF PHOSPHOINOSITIDE 3-KINASE ISOFORMS ALPHA AND BETA IN GLYCOPROTEIN VI-INDUCED PLATELET SIGNALING TO PROCOAGULANT ACTIVITY
|
| Munnix I.C.A., Cosemans J.M.E.M., van der Meijden P.E.J., van Montfoort A.P.A., Feijge M.A.H., Farndale R.W., Koyasu S., Heller R., Sage S.O., Jackson S.P., Heemskerk J.W.M. |
| |
|
SPERM MEDIATED HUMAN COAGULATION FACTOR VIII GENE TRANSFER AND EXPRESSION IN TRANSGENIC MICE
|
| Yin J., Shi G., Yao G., Lu P., Huang H., Liu X., Wang X., Wang H. |
| |
|
SPIRAL COMPUTED TOMOGRAPHY IN THE EVALUATION OF THE RESOLUTION OF PULMONARY EMBOLISM AFTER A STANDARD COURSE OF ANTICOAGULATION
|
| Cosmi B., Nijkeuter M., Valentino M., Ageno W., Donadini M., Barozzi L., Palareti G. |
| |
|
SPONTANEOUS DEEP VEIN THROMBOSIS OF THE UPPER EXTREMITIES: RISK FACTORS AND LONG TERM FOLLOW UP
|
| Lechner D., Wiener C., Eichinger S., Weltermann A., Eischer L., Kyrle P.A. |
| |
|
STABILITY OF COAGULATION SYSTEM BASELINE STATE: A MATHEMATICAL MODEL
|
| Malush N.A., Khanin M.A., Tyurin K.V. |
| |
|
STABILITY OF COAGULATION SYSTEM BASELINE STATE: A MATHEMATICAL MODEL
|
| Malush N.A., Khanin M.A., Tyurin K.V. |
| |
|
STABILITY OF HIGH PURITY THERAPEUTIC FVIII/VWF CONCENTRATE AFTER RECONSTITUTION
|
| Grancha S., Jorquera J.I. |
| |
|
STANDARDIZATION OF MICROPARTICLE COUNTING USING FLOW CYTOMETRY: NEW OPTIONS AND TOOLS FOR THE CONTROL OF CRITICAL INSTRUMENT SETTINGS
|
| Robert S., Poncelet P., Camoin L., Dignat-Georges F. |
| |
|
STAPHYLOCOCCUS AUREUS FIBRONECTIN BINDING PROTEINS DO NOT PLAY A ROLE IN THROMBUS FORMATION
|
| Moore N., Loughman A., Meade G., Kerrigan S., Foster T.J., Cox D. |
| |
|
STATINS INHIBIT LPS-INDUCED MONOCYTE-ASSOCIATED, BUT NOT PLATELET- OR MICROPARTICLE-ASSOCIATED TISSUE FACTOR (TF) EXPRESSION IN VIVO AND EX VIVO
|
| Ross C.S., Slaba I., Spiel A., Jilma B., Kemeny G., Bach R.R., Key N.S. |
| |
|
STERILIZATION OF PLATELET CONCENTRATES BY IRRADIATION WITH SHORT-WAVE ULTRAVIOLET LIGHT
|
| Mohr H., Gravemann U., Bayer A., Müller T.H. |
| |
|
STICKY PLATELET SYNDROME (SPS) AND PLATELET GLYCOPROTEIN POLYMORPHISMS
|
| Kubisz P., Musial J., Stasko J., Ivankova J., Dobrotova M., Plamenova I., Bartosova L., Chudy P. |
| |
|
STRATEGIES FOR CHARACTERIZING THE PHOSPHO- AND GLYCOPROTEOMES OF MICROPARTICLES DERIVED FROM INTERLEUKIN-1BETA STIMULATED PANCREATIC BETA-CELLS
|
| Jensen S.S., Østergaard O., McGuire J.M., Pociot F., Larsen M.R. |
| |
|
STRUCTURAL AND THERMODYNAMIC EFFECTS OF TYPE 2M AND TYPE 2B VWD MUTATIONS IN THE A1 DOMAIN OF VWF
|
| Auton M., Moake J., Cruz M.A. |
| |
|
STRUCTURE AND REGULATION OF A VENOM PROTHROMBIN ACTIVATOR GENE IN TROPIDECHIS CARINATUS SNAKE: A UNIQUE CIS-REGULATORY REGION RESPONSIBLE FOR THE ELEVATED EXPRESSION IN THE VENOM GLAND
|
| Reza M., Swarup S., Kini R.M. |
| |
|
STRUCTURE OF FIBRIN: IMPACT ON CLOT STABILITY
|
| Weisel J.W. |
| |
|
STRUCTURE OF NATIVE PROTEIN C INHIBITOR PROVIDES INSIGHT INTO ITS MULTIPLE FUNCTIONS
|
| Li W., Huntington J.A. |
| |
|
STRUCTURE OF U-PA/U-PA RECEPTOR COMPLEX
|
| Huang M. |
| |
|
STRUCTURE-FUNCTION ANALYSIS OF THE BINDING PROPERTIES AND ENZYMATIC ACTIVITY OF FACTOR VII ACTIVATING PROTEASE (FSAP) USING RECOMBINANT MUTANT PROTEINS
|
| Muhl L., Weimer T., Preissner K.T., Kanse S.M. |
| |
|
STRUCTURE-FUNCTION RELATIONSHIP OF FXIIIB: ITS ROLES IN OLIGOMER ASSEMBLY, STABILITY AND ACTIVITY OF COAGULATION FACTOR XIII
|
| Souri M., Iwata H., Ichinose A. |
| |
|
STRUCTURE-FUNCTION RELATIONSHIPS OF POLYPHENOLS AND THE MODULATION OF PLATELET FUNCTION AND SIGNALLING
|
| Wright B., Gibbins J.M., Lovegrove J.A. |
| |
|
STUDIES OF mRNA IN PATIENTS WITH UNDETECTABLE MUTATIONS IN GENOMIC DNA
|
| Knobe K.E., Sjörin E., Ljung R.C.R. |
| |
|
STUDY DESIGN, QUALITY OF EVIDENCE AND GUIDELINES
|
| Schunemann H. |
| |
|
STUDY OF ANTI-ANGIOGENESIS EFFECT INDUCED BY MER IN VITRO AND ITS MECHANISM
|
| Fan L., Zhou M.Y., Shen F., Xie L.Q., Ruan C.G. |
| |
|
STUDY OF IN VIVO AND IN VITRO ADMINISTERED ASPIRIN'S ANTIPLATELET EFFECT: POSSIBLE MECHANISMS OF ASPIRIN RESISTANCE
|
| Kiss N., Toth-Zsamboki E., Beres B.J., Vargova K., Kerecsen G., Preda I., Kiss R.G. |
| |
|
STUDY OF PLATELETS FACTOR V UPTAKE IN HUMAN MEGAKARYOCYTE CULTURES FROM PATIENTS WITH PARAHEMOPHILIA
|
| Spiezia L., Radu C., Chiriu A., Tognin G., Rossetto V., Pagnan A., Simioni P. |
| |
|
STUDY OF RECOMBINANT FACTOR VIIA ACTION MECHANISM: A MATHEMATICAL MODEL
|
| Khanin M.A., Tyurin K.V., Platonov A. |
| |
|
STUDY OF THE METHYLENETETRAHYDROFOLATE REDUCTASE C677T POLYMORPHISM IN HELLP SYNDROME PATIENTS
|
| Nagy B., Hupuczi P., Rigo B., Szabo G., Berkes E., Sziller I., Papp Z. |
| |
|
STUDY OF THE STRUCTURAL DETERMINANTS OF ARTERIAL VESSEL WALL THROMBOGENICITY
|
| Wohner N., Komorowicz E., Kolev K. |
| |
|
STUDY ON THE DETECTION AND APPLICATION OF THE LEVEL OF TISSUE FACTOR PATHWAY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND CEREBRAL INFARCTION
|
| Xiong S.L., Wen Z.B., He S.L. |
| |
|
SUB-CELLULAR LOCALIZATION REGULATES THE INTERACTION BETWEEN THE PLATELET INTEGRIN IIB3 AND ICLN
|
| Larkin D., Kiernan A., Moran N. |
| |
|
SUBCLINICAL HYPOTHYROIDISM AND DEEP VENOUS THROMBOSIS. A PILOT CROSS-SECTIONAL STUDY
|
| Squizzato A., Romualdi E., Manfredi E., Gerdes V.E.A., Buller H.R., Venco A., Ageno W. |
| |
|
SUBMASSIVE PULMONARY EMBOLISM: ROLE OF THROMBOLITIC THERAPY
|
| Barchitta A., Ruzza L., La Spisa C., Latella R., Cianci V., Tosato F. |
| |
|
SUBSTRATE SPECIFICITY STUDY OF CARBOXYPEPTIDASE U (TAFIA): DEVELOPMENT OF HIGHLY SELECTIVE CPU SUBSTRATES AS USEFUL TOOLS FOR ASSAY DEVELOPMENT
|
| Willemse J.L., Polla M., Olsson T., Hendriks D. |
| |
|
SUCCESSFUL ANGIOGRAPHIC EMBOLIZATION OF RECURRENT ELBOW JOINT BLEEDS IN FIVE PATIENT WITH SEVERE HAEMOPHILIA A
|
| Klamroth R., Essers E., Gottstein S., Wilaschek M., Oldenburg J. |
| |
|
SUCCESSFUL ANTICOAGULATION OF INFANTS TO ADULTS WITH BIVALIRUDIN IN EXTRACORPOREAL MEMBRANOUS OXYGENATION (EMCO)
|
| Dager W., Pretzlaff R., Raff G., Calhoun R., Gosselin R.C., King J., White R. |
| |
|
SUCCESSFUL IMMUNE TOLERANCE INDUCTION (ITI) OF HIGH-RESPONDING INHIBITORS WITH A HIGH PURITY FVIII/VWF CONCENTRATE
|
| Bidlingmaier C., Escuriola-Ettingshausen C., Jager R., Klamroth R., Kurnik K., Male C., Marosi A., Nemes L., Taube T., Kreuz W. |
| |
|
SUCCESSFUL IMMUNE TOLERANCE INDUCTION TREATMENT OF THERAPY-RESISTENT ACQUIRED HAEMOPHILIA WITH HIGH INHIBITOR TITER: A CASE REPORT
|
| Ilonczai P., Schlammadinger A., Oláh Z., Rázsó K., Bereczky Z., Boda Z. |
| |
|
SUCCESSFUL INHIBITOR-ELIMINATION W ITH RITUXIMAB IN ONE PATIENT WITH A CARRIER STATE FOR HEMOPHILIA A AND 4 PATIENTS WITH ACQUIRED HEMOPHILIA A
|
| Huth-Kühne A., Findeklee J., Bajanova M., Lages P., Zimmermann R. |
| |
|
SUCCESSFUL LONG TERM EXPRESSION OF FVIII AFTER GENE DELIVERY OF NOVEL ADENO-ASSOCIATED VIRAL VECTOR SEROTYPES IN HEMOPHILIA A DOGS
|
| Sabatino D.E., Lange A.M., Sarkar R., Dillow A.M., Nichols T.C., Arruda V.R., Kazazian H.H. |
| |
|
SUCCESSFUL MANAGEMENT OF BLEEDING WITH A PASTEURIZED FVIII/VWF CONCENTRATE IN A WOMAN AFFECTED BY TYPE 2A VON WILLEBRAND DISEASE UNDERGOING UTERINE CERVIX CONIZATION
|
| Lapecorella M., Mascaretti G., Colageo E., Napolitano M., Mariani G. |
| |
|
SUCCESSFUL MANAGEMENT OF LATE OBSTETRIC COMPLICATIONS IN THE ANTIPHOSPHOLIPID SYNDROME
|
| Austin S.K., Nash M.J., Peebles D., Cohen H. |
| |
|
SUCCESSFUL OUTCOME OF THE WTCCC GENOME-WIDE ASSOCIATION STUDY SHOWS THAT BLOOD DONORS REFLECT THE UK POPULATION STRUCTURE AND CAN BE USED AS COMMON CONTROLS
|
| Koch K. |
| |
|
SUCCESSFUL PREGNANCY OUTCOME IN A WOMAN WITH HOMOZYGOUS ANTITHROMBIN DEFICIENCY (99 LEUPHE MUTATION)
|
| Alguel G., Jochmans K., Simanek R., Quehenberger P., Langer M., Pabinger I. |
| |
|
SUCCESSFUL TREATMENT OF HIGH TITRE FACTOR VIII (FVIII) INHIBITOR IN TWO PATIENTS WITH MILD AND MODERATE HAEMOPHILIA A WITH RITUXIMAB ALONE
|
| Sigaud M., Voisin S., Lefrancois A., Fouassier M., Ternisien C., Hamidou M., Trossaert M. |
| |
|
SUCCESSFUL TREATMENT OF PATIENTS WITH INHIBITORS TO COAGULATION FACTOR VIII AND IX BY TREATING CONCOMITANT HEPATITIS C
|
| Eisert R.M., Varvenne M., Bolte O., Ganser A. |
| |
|
SUCCESSFUL USE OF RECOMBINANT FACTOR VIIA (RFVIIA, NOVOSEVEN) IN TWO PATIENTS WITH BERNARD SOULIER SYNDROME AND DENTAL EXTRACTION
|
| Gerhardt A., Scharf R.E., Zotz R.B. |
| |
|
SULFATION OF THE 3-HYDROXYL GROUP OF THE REDUCING UNIT (H) ON ALKYLATED SULFATED PENTASACCHARIDE IS RESPONSIBLE FOR A HIGH AFFINITY FOR ANTITHROMBIN AND LONGER HALF LIFE IN ANIMALS
|
| Herault J., Savi P., Duchaussoy P., Petitou M., Bono F., Herbert J. |
| |
|
SUPERFICIAL THROMBOSIS (RATS AND RABBITS) AND ITS TREATMENT WITH THROMBOLYTIC PREPARATION LONGOLYTIN
|
| Sharkova T.S., Podorolskaya L.V., Serebryakova T.N., Neumivakin L.V., Khromov I.S., Khokhlov N.V., Agniullin J.V. |
| |
|
SUPERIOR EFFECT OF EPTIFIBATIDE ADDED TO CLOPIDOGREL ON BIOMARKER EXPRESSION DETECTED BY FLUOROKINE MULTI-ANALYTE PROFILING IN PATIENTS UNDERGOING ELECTIVE PCI
|
| Gurbel P.A., Bliden K.P., Kreutz R.P., DiChiara J., Hamed M., Tantry U.S. |
| |
|
SUPERWARFARIN INTOXIFICATION: HEMATURIA IS A MAJOR CLINICAL MANIFESTATION
|
| Wu Y.F., Su P.Y., Wang C.C., Lin H.Y., Chung T.Y., Chang C.H., Shen M.C. |
| |
|
SURGERY IN HEMOPHILIA PATIENTS WITH INHIBITORS: REPORT OF 91 SURGICAL PROCEDURES
|
| Rodriguez-Merchan E.C., Quintana-Molina M., Jiménez-Yuste V., de la Corte-Rodriguez H., Hernández-Navarro F. |
| |
|
SURGICAL BLEEDING AFTER PREOPERATIVE UNFRACTIONATED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN AT CORONARY BYPASS SURGERY
|
| Renda G., Di Pillo R., D'Alleva A., Sciartilli A., Zimarino M., De Candia E., Landolfi R., Di Giammarco G., De Caterina R. |
| |
|
SURGICAL REMOVAL OF A PSEUDOTUMOR IN A PATIENT WITH HEMOPHILIA A AND INHIBITORS: A COLOMBIAN CASE STUDY
|
| Sossa Melo C.L., Jimenez Sanguino S. |
| |
|
SWITCHING PREVIOUSLY TREATED PATIENTS (PTPS) FROM PLASMA-DERIVED TO RECOMBINANT FACTOR VIII IN THE CONTEXT OF AN IMMUNOLOGICAL CHALLENGE CAN PROVOKE INHIBITOR FORMATION
|
| Rangarajan S., Bevan D. |
| |
|
SWITCHING PREVIOUSLY TREATED PATIENTS (PTPS) FROM PLASMA-DERIVED TO RECOMBINANT FACTOR VIII IN THE CONTEXT OF AN IMMUNOLOGICAL CHALLENGE CAN PROVOKE INHIBITOR FORMATION
|
| Rangarajan S., Bevan D.H. |
| |
|
SYMPTOMATIC THROMBOSIS COMPLICATIONS IN VENOUS MALFORMATION
|
| Khau Van Kien A., Bigorre M., Galanaud J., Vernhet H., Chammas M., Laroche J., Bessis D., Jaussent A., Daily C., Quéré I. |
| |
|
SYNDECAN-4 CONTRIBUTES TO ENDOTHELIAL TUBULOGENESIS THROUGH INTERACTIONS WITH TWO MOTIFS INSIDE THE PRO-ANGIOGENIC N-TERMINAL DOMAIN OF THROMBOSPONDIN-1
|
| Legrand C.M., Nunes S.S., Ferrari do Outeiro Bernstein M.A., Juliano L., Nader H.B., Woods A., Morandi V. |
| |
|
SYNERGISM BETWEEN GI ACTIVATION AND CA2+ MOBILIZATION IN PLATELET THROMBOXANE A2 FORMATION
|
| Kaneko M., Kanno N., Satoh K., Ozaki Y., Yatomi Y. |
| |
|
SYNERGISTIC EFFECT OF HEPARIN, LOW MOLECULAR WEIGHT HEPARIN AND PACLITAXEL ON CYTOTOXICITY FOR BREAST CARCINOMA CELLS IN CULTURE
|
| Clutterbuck R.D., Scully M.F., Kakkar A.K. |
| |
|
SYNERGISTIC EFFECT OF SMOKING ON PLATELET RESPONSIVENESS TO CLOPIDOGREL
|
| Gurbel P.A., Lawal L., Singla A., Bailon O.V., Bliden K., Tantry U. |
| |
|
SYNERGISTIC EFFECTS OF HYPOFIBRINOLYSIS AND GENETIC AND ACQUIRED RISK FACTORS IN VENOUS THROMBOSIS
|
| Meltzer M.E., Doggen C.J.M., de Groot P.G., Rosendaal F.R., Lisman T. |
| |
|
SYNTHESIS AND PROPERTIES OF BIOTINYLATED ANTITHROMBOTIC OLIGOSACCHARIDES
|
| Duchaussoy P., Savi P., Herault J., Millet L., Petitou M., Schaeffer P., Bono F., Herbert J. |
| |
|
SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS OF PROPHYLACTIC CLOTTING FACTOR CONCENTRATE IN HEMOPHILIA
|
| Iorio A., Stobart K. |
| |
